Site References
- Drukker, C.A., et al. Int. J. Cancer. (Jan 2013) 133: 929–936 (RASTER).
- Buyse M. et al. JNCI. (Sept 2006) 98 (17): 1183–1192.
- Carlson JJ, et al. Breast Cancer Res Treat. (Aug 2013) 141(1): 13–22.
- Cusumano PG, et al. The Breast. 2014. doi: 10.1016/j.breast.2014.02.011.
- van ‘t Veer et al. Nature. (Jan 2002) 415, 530-536
- McGee et al. EMBO Reports, (Oct 2006) doi: 10.1038/sj.embor.7400839
- Knauer et al. Breast Cancer Res Treat, (Mar 2010) 120(3):655-661.
- US FDA 510K Clearance – K101454
- Delahaye L et al. Personalized Medicine. (2013) 10(3):801-811
- Glück S. et al. Breast Cancer Res Treat. (June 2013) 139(3):759-767
- Cristofanilli M. et al. Cancer Res. 2012;72(24 Suppl):Abstract nr P3-05-01.
- Krijgsman O. et al. Breast Cancer Res Treat. (Aug 2012) 133:37-47
- Tian, S. et al. Biomarker Insights. (Nov 2010) 5: 129-138
- Whitworth P. et al. Annals of Surg. Onc. (Oct 2014) 10:326-7
- Roepman P. et al. Clin Cancer Res. (Nov 2009) 15:7003-7011
- Oyama T. et al. Breast Cancer. (Apr 2007) 14:182–8
- Allred DC. The Oncologist. (Nov 2008) 13(11):1134-1136
- Viale G. et al. Annals of Oncology. (Apr 2014) 25(4):816-823
- Maak M. et al. Annals of Surgery. (Jun 2013) 257(6):1053-1058
- Benson AB 3rd et al. J Clin Oncol. (2004) 22:3408–3419
- Salazar R. et al. JCO. (Jan 2011) 29(1):17-24
- Tabernero J. et al. J Clin Oncol 30, 2012 (suppl 4; abstr 384)
- American Cancer Society. “Tamoxifen and Raloxifene.” Cancer.org. Web. 17 July 2014